The Delhi High Court Friday set aside the government decision to ban private firms from producing and selling oxytocin, a drug used for inducing labour contractions and controlling bleeding.
A bench of Justices S Ravindra Bhat and AK Chawla said the government's decision was arbitrary and unreasonable.
The bench also said that there was no scientific basis behind the Centre's decision restricting private companies from making or supplying the drug, which helps new mothers lactate, to prevent its alleged misuse in the dairy sector for increasing milk production.
As per the Centre's April 27 notification, the state-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) was solely allowed by the Centre to make the drug to meet the country's needs.
The high court on August 31 had suspended till September 30 the central government's prohibition on sale and manufacture of oxytocin by private companies for domestic use. The stay was later extended till December 15
Factory Making Illegal Oxytocin Injections Busted In Delhi, Owner Arrested Delhi Court Orders Action Against Spurious Oxytocin Use In Dairy Colonies "Love Hormone" Oxytocin May Not Work As We Think, New Study Suggests Student Dies, 2 Others Trapped In Delhi Coaching Centre's Flooded Basement At Olympics Opening Ceremony, Drag Parody Of 'The Last Supper' Draws Flak US Scientists Play God: New Element Created In A Lab Experiment DSSSB Exam Schedule 2024 Released For Recruitment To Various Posts AAP's Atishi Calls For Meeting After Delhiites Complain Of Blue Tap Water Woman Gym Trainer, 21, Killed Inside Delhi Flat Track Latest News Live on NDTV.com and get news updates from India and around the world.